Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO Subscriptions PDA Services My JCO Customer Service

Journal of Clinical Oncology, Vol 24, No 30 (October 20), 2006: pp. 4833-4839
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.07.5937

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Timmerman, R.
Right arrow Articles by Fletcher, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Timmerman, R.
Right arrow Articles by Fletcher, J.
Related Articles
Right arrowRelated Correspondence

Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer

Robert Timmerman, Ronald McGarry, Constantin Yiannoutsos, Lech Papiez, Kathy Tudor, Jill DeLuca, Marvene Ewing, Ramzi Abdulrahman, Colleen DesRosiers, Mark Williams, James Fletcher

From the Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX; and the Department of Radiation Oncology, Department of Medicine (Biostatistics), Division of Pulmonology, and Department of Radiology (Nuclear Medicine), Indiana University School of Medicine, Indianapolis, IN

Address reprint requests to Robert Timmerman, MD, Department of Radiation Oncology, The University of Texas Southwestern Medical Center, 5801 Forest Park Rd, Dallas, TX 75390-9183; email: robert.timmerman{at}utsouthwestern.edu

PURPOSE: Surgical resection is standard therapy in stage I non–small-cell lung cancer (NSCLC); however, many patients are inoperable due to comorbid diseases. Building on a previously reported phase I trial, we carried out a prospective phase II trial using stereotactic body radiation therapy (SBRT) in this population.

PATIENTS AND METHODS: Eligible patients included clinically staged T1 or T2 (≤ 7 cm), N0, M0, biopsy-confirmed NSCLC. All patients had comorbid medical problems that precluded lobectomy. SBRT treatment dose was 60 to 66 Gy total in three fractions during 1 to 2 weeks.

RESULTS: All 70 patients enrolled completed therapy as planned and median follow-up was 17.5 months. The 3-month major response rate was 60%. Kaplan-Meier local control at 2 years was 95%. Altogether, 28 patients have died as a result of cancer (n = 5), treatment (n = 6), or comorbid illnesses (n = 17). Median overall survival was 32.6 months and 2-year overall survival was 54.7%. Grade 3 to 5 toxicity occurred in a total of 14 patients. Among patients experiencing toxicity, the median time to observation was 10.5 months. Patients treated for tumors in the peripheral lung had 2-year freedom from severe toxicity of 83% compared with only 54% for patients with central tumors.

CONCLUSION: High rates of local control are achieved with this SBRT regimen in medically inoperable patients with stage I NSCLC. Both local recurrence and toxicity occur late after this treatment. This regimen should not be used for patients with tumors near the central airways due to excessive toxicity.

Supported by Grant No. 5R21CA097721-02 from the United States National Institutes of Health.

Presented in an oral format at the Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Denver, CO, October 16-20, 2005.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.


Related Correspondence

  • Stereotactic Radiotherapy for Centrally Located Early-Stage Lung Tumors
    Suresh Senan, Niels J.A. Haasbeek, Egbert F. Smit, and Frank J. Lagerwaard
    JCO 2007 25: 464 [Full Text]


This article has been cited by other articles:


Home page
The OncologistHome page
J. P. van Meerbeeck, S. Meersschout, R. De Pauw, I. Madani, and W. De Neve
Modern Radiotherapy as Part of Combined Modality Treatment in Locally Advanced Non-Small Cell Lung Cancer: Present Status and Future Prospects
Oncologist, June 1, 2008; 13(6): 700 - 708.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
C. J.A. Haasbeek, S. Senan, E. F. Smit, M. A. Paul, B. J. Slotman, and F. J. Lagerwaard
Critical Review of Nonsurgical Treatment Options for Stage I Non-Small Cell Lung Cancer
Oncologist, March 1, 2008; 13(3): 309 - 319.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. A. Cesaretti, A. Pennathur, B. S. Rosenstein, S. J. Swanson, and H. C. Fernando
Stereotactic Radiosurgery for Thoracic Malignancies
Ann. Thorac. Surg., February 1, 2008; 85(2): S785 - S791.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
C. J. A. Haasbeek, S. Senan, E. F. Smit, F. J. Lagerwaard, D. E. Dupuy, C. J. Simon, T. A. DiPetrillo, T. Ng, and W. W. Mayo-Smith
CT-guided Pulmonary Radiofrequency Ablation
Radiology, January 1, 2008; 246(1): 334 - 335.
[Full Text] [PDF]


Home page
ChestHome page
W. J. Scott, J. Howington, S. Feigenberg, B. Movsas, and K. Pisters
Treatment of Non-small Cell Lung Cancer Stage I and Stage II: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 234S - 242S.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. D. Timmerman, B. D. Kavanagh, L. C. Cho, L. Papiez, and L. Xing
Stereotactic Body Radiation Therapy in Multiple Organ Sites
J. Clin. Oncol., March 10, 2007; 25(8): 947 - 952.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Brada, M. Pijls-Johannesma, and D. De Ruysscher
Proton Therapy in Clinical Practice: Current Clinical Evidence
J. Clin. Oncol., March 10, 2007; 25(8): 965 - 970.
[Full Text] [PDF]


Home page
JCOHome page
S. Senan, N. J.A. Haasbeek, E. F. Smit, and F. J. Lagerwaard
Stereotactic Radiotherapy for Centrally Located Early-Stage Lung Tumors
J. Clin. Oncol., February 1, 2007; 25(4): 464 - 464.
[Full Text] [PDF]


Home page
JCOHome page
R. D. Timmerman
In Reply
J. Clin. Oncol., February 1, 2007; 25(4): 465 - 465.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 Site Map

Copyright © 2006 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online